129 related articles for article (PubMed ID: 11341595)
1. Prognostic factors in node-negative squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Shibakita M; Ohno S; Masunaga R; Kotoh T; Kubota H; Nagasue N
Int J Surg Investig; 2000; 1(5):389-95. PubMed ID: 11341595
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Tabara H; Masunaga R; Kotoh T; Kubota H; Nagasue N
Arch Surg; 1999 Jan; 134(1):50-4. PubMed ID: 9927130
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
5. Outcome of histologically node-negative esophageal squamous cell carcinoma.
Tabira Y; Yasunaga M; Sakaguchi T; Yamaguchi Y; Okuma T; Kawasuji M
World J Surg; 2002 Dec; 26(12):1446-51. PubMed ID: 12297913
[TBL] [Abstract][Full Text] [Related]
6. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
9. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
10. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
11. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Kohno H; Nagasue N
J Surg Oncol; 1999 Oct; 72(2):88-93. PubMed ID: 10518105
[TBL] [Abstract][Full Text] [Related]
13. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Sato H; Daiko H; Nakanishi Y
Eur J Cardiothorac Surg; 2001 Jun; 19(6):887-93. PubMed ID: 11404147
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma.
Ye K; Xu JH; Sun YF; Lin JA; Zheng ZG
Genet Mol Res; 2014 Aug; 13(3):6411-9. PubMed ID: 25158259
[TBL] [Abstract][Full Text] [Related]
16. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer patients surviving 6 years after esophagectomy.
Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Fujii T; Shibakita M; Ohno S; Ueda S; Kohno H; Nagasue N
Langenbecks Arch Surg; 2002 Jun; 387(2):77-83. PubMed ID: 12111259
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
19. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
Li H; Zhang Y; Cai H; Xiang J
Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Nakanishi Y
Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]